Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care

PASADENA and PALO ALTO, Calif. – February 11, 2020 –  Autism Learning Partners (“ALP”), a national leader in the treatment of autism and other developmental disabilities, and Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today a partnership designed to accelerate the diagnosis of autism to enable interventions earlier, when there is the greatest potential to…

Cognoa Executives to Speak at DTx West 2020

PALO ALTO, Calif. — February 10, 2020 — Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that three company executives will be on stage at the third annual DTx West 2020, taking place in San Mateo, California, February 18 to 20.   All events take place on the first day of the conference, Tuesday, February 18.…

Cognoa Named to the 2020 Global Digital Health 100 By The Journal of mHealth

International Health Technology Publication Annual List Recognizes Innovation and Leaders in Health Technology Palo Alto, Calif., and London – January 29, 2020 –  Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, has been named to the 2020 Global Digital Health 100 list by The Journal of mHealth. Cognoa’s digital therapeutics will advance the standard of care by…

Digital therapeutics can solve the greatest unmet need in behavioral healthcare: early intervention

Cognoa CMO, Sharief Taraman, MD, DABPN, DABPM, FAAP, authored a MedCity News Influencer article about the potential of digital therapeutics and ai to empower pediatricians and make early intervention possible for more children. Our mental and behavioral health is largely determined by how the brain develops during the first few years of life when the brain is most actively developing.…

Cognoa Wins 2019 Fierce Innovation Life Science Award

Palo Alto, Calif., December 18, 2019 –  Cognoa, a company at the forefront of pediatric behavioral health, has won the Fierce Innovation Life Science Award for Technology Innovation. Cognoa’s digital therapeutics will advance the standard of care by giving every child the opportunity to receive treatments earlier when they can have the greatest impact. Currently, diagnosis and treatment of behavioral…

children looking at globe

Closing the Gaps in Pediatric Behavioral Health

Currently, most pediatricians choose to refer children to a specialist to be diagnosed and treated for behavioral conditions such as autism — often with waitlists of a year to three years. Nationwide, we continue to face an enormous and growing shortage of specialists, so the heartbreaking reality for most children and families is delayed diagnosis and late access to treatments.…

Cognoa Selected as Finalist in Fierce Innovation Awards – LifeSciences Edition 2019

Cognoa develops AI-powered digital therapeutics and medicines that advance the standard of care in pediatric behavioral health and improve lifelong outcomes for children Palo Alto, Calif., December 5, 2019 –  Cognoa, a company at the forefront of pediatric behavioral health, announced today that it has been selected as a finalist in Questex’s Fierce Innovation Awards – LifeSciences Edition 2019, a…

cognoa-logo

Cognoa Appoints Seasoned Biotech Executive as CFO

James Welch brings two decades experience scaling high-growth companies to Cognoa as company prepares for commercialization PALO ALTO, Calif.– December 2, 2019 –Cognoa, a company at the forefront of pediatric behavioral health, announced today that James (Jim) H. Welch has been appointed Chief Financial Officer. Welch will oversee financial planning, operations and investor relations as the company advances its digital…

cognoa-logo

Cognoa to Participate in BTIG DIGITAL HEALTH and EVERCORE ISI HealthCONx Conferences.

Palo Alto, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking at two upcoming investor conferences: BTIG Digital Health 2019: Industry Innovators on What’s Next. Panel entitled, “Developing Commercial Models for Prescription Digital Therapeutics” on Wednesday, November 20 at 1:35 p.m. Eastern Time in New…

Location

Social